Bothell, Washington
February 7, 2002

EDEN Bioscience Corporation (Nasdaq:EDEN), which develops, manufactures and markets innovative, natural products for improving crop production and protecting plants, today announced financial results for its fourth quarter and fiscal year ended December 31, 2001. Separately, the company announced today that it has received approval from Germany's Federal Biological Research Centre for Agriculture and Forestry for the use of Messenger(R) as a plant strengthener (see separate news release).

As the company reported on January 3, 2002, there were no sales of Messenger in the fourth quarter of 2001, which compares to net revenue of $439,000 in the third quarter of 2001 and $612,000 in the fourth quarter of 2000. Revenue is derived solely from sales of Messenger. Net revenue for the year ended December 31, 2001 was $3.5 million, compared to $1.2 million in 2000. As the company further reported on January 3, 2002, EDEN estimates that distributors sold approximately 760,000 ounces of Messenger to growers during 2001. Further, EDEN estimates that Messenger inventory owned by distributors increased during the year by approximately 450,000 ounces, leaving approximately 850,000 ounces in distributor inventory at year-end.

Net loss in the fourth quarter was $7.5 million, or $0.31 per weighted average common share, compared to a net loss of $2.9 million, or $0.12 per weighted average common share in the fourth quarter of 2000. Net loss for 2001 was $23.7 million, or $0.99 per weighted average common share, compared to a net loss of $15.7 million, or $1.89 per weighted average common share in 2000. The results in 2000 include an expense of approximately $2.3 million or $0.28 per weighted average common share for a commitment fee paid, and the fair value of warrants issued, in connection with the establishment of credit facilities. Per-share loss amounts for the quarter are based on weighted average common shares of 24.0 million in 2001 and 23.6 million in 2000. Annual per share loss amounts are based on weighted average common shares of 24.0 million in 2001 and 8.3 million in 2000.

"In 2001 we learned how challenging it is to introduce a new technology into a tough agricultural market," said Brad Powell, interim president and CFO. "In 2002, our focus will be to get Messenger used by growers. We will implement aggressive sales and marketing programs to increase Messenger adoption and use, allowing Messenger to demonstrate its value to growers."

Cash and investments as of December 31, 2001 totaled $48.3 million, compared with $56.7 million at September 30, 2001. The company believes this balance is sufficient to fund operations for at least the next 18 months.

EDEN Bioscience is a plant technology company focused on developing, manufacturing and marketing innovative natural products for agriculture. EDEN believes its technology and initial product, Messenger, provides growers with a new tool to improve crop production and protection. Messenger, which received EPA approval for full commercial use in April 2000, is based on naturally occurring proteins called "harpins," which activate natural plant defense systems to protect against disease and pests, and simultaneously activate plant growth systems, improving crop yield and quality. It has been tested in hundreds of field trials in many countries and on more than 40 crops including: citrus, cotton, strawberries, tomatoes, peppers, melons, wheat, rice, corn, peanuts, tobacco, grapes and others.